Point72 Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,758
Closed -$1.43M 2525
2024
Q3
$1.43M Sell
24,758
-232,561
-90% -$11.4M ﹤0.01% 1302
2024
Q2
$10.4M Buy
257,319
+115,819
+82% +$4.59M 0.03% 601
2024
Q1
$5.94M Buy
141,500
+35,300
+33% +$1.38M 0.01% 913
2023
Q4
$4.07M Buy
+106,200
New +$3.54M 0.01% 1000
2022
Q4
Sell
-236,400
Closed -$9.22M 1845
2022
Q3
$9.22M Buy
236,400
+36,849
+18% +$1.69M 0.04% 528
2022
Q2
$7.7M Sell
199,551
-76,749
-28% -$2.92M 0.03% 588
2022
Q1
$13.4M Buy
+276,300
New +$14.3M 0.05% 436

Other funds holding ASTH

Point72 Asset Management's ASTH Position: Q4 2024 in Review

Point72 Asset Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 24,758 shares — an estimated $1.43M sold.

Point72 Asset Management first reported a position in ASTH in Q1 2022 and held it in 7 quarters. The position peaked at $13.4M in Q1 2022. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Point72 Asset Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Point72 Asset Management sold 24,758 Astrana Health shares in Q4 2024, an estimated $1.43M.
  • Point72 Asset Management first reported a position in Astrana Health in Q1 2022 and held it in 7 quarters.
  • Point72 Asset Management's Astrana Health position peaked at $13.4M in Q1 2022.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.